Centre asks MSME drugmakers to submit action plans on quality compliance in 3 months or risk closure
small and medium drugmakers three months to submit their action plans to upgrade plants and comply with the World Health Organization’s good manufacturing practices (GMP) for life-saving ...
Signals Start of New Commercialization Phase for LineaRx Subsidiary - - Company Negotiating GMP Supply Agreement - - Company ...
Windlas Biotech's new GMP-certified injectable facility expands manufacturing capabilities for global pharmaceutical markets.
Macsen Labs Group announces the commencement of construction of its new Active Pharmaceutical Ingredient (API) manufacturing ...
The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.
Atara, Pierre Fabre hit a hurdle with Ebvallo in the US courtesy of manufacturing plant's shortfalls
As partners Atara Biotherapeutics and Pierre Fabre Laboratories work to grow the reach of their novel T-cell immunotherapy ...
STONY BROOK, NY / ACCESSWIRE / January 10, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the completion ...
today announced the completion of the buildout of its new Good Manufacturing Practices (GMP) manufacturing facility (the "facility") within its Stony Brook, New York, headquarters and readiness to ...
Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback